This Company Just Endorsed New Patient Advocacy Guidelines
<a href="https://pixabay.com/users/mohamed_hassan/">mohamed_hassan</a> / Pixabay

This Company Just Endorsed New Patient Advocacy Guidelines

According to a story from globenewswire.com, the biopharmaceutical company Orphazyme has officially endorsed a set of guidelines that outline how rare disease patient advocacy organizations and drug companies should interact…

Continue Reading
New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program
<a href="https://pixabay.com/users/QuinceMedia/">QuinceMedia</a> / Pixabay

New Rare Diseases Have Been Added to the Patient Advocate Foundation’s Co-Pay Relief Program

The Patient Advocate Foundation has recently begun to expand the reach of its popular Co-Pay Relief program. The Co-Pay Relief program is designed to provide financial assistance to qualifying patients.…

Continue Reading
Close Menu